Management of Hyperprolactinemia and Hyperandrogenism

Initial Diagnostic Confirmation

The Endocrine Society recommends confirming persistent hyperprolactinemia with repeat morning resting samples, and immediately excluding primary hypothyroidism with TSH and free T4 measurements, while simultaneously evaluating elevated DHEA-S to determine its source 1, 2
Repeat prolactin measurement as a morning resting sample to confirm hyperprolactinemia, as a single elevated value can be spurious due to stress or prolactin pulsatility 1, 2
If prolactin is modestly elevated, obtain 2-3 samples at 20-60 minute intervals via indwelling cannula to exclude stress-related elevation 3, 4, 5
The threshold for abnormal prolactin is >20 μg/L, with prolactin levels >4,000 mU/L typically indicating prolactinoma 3, 5, 1
Check for macroprolactin if prolactin is mildly or incidentally elevated, as macroprolactinemia occurs in 10-40% of adults with hyperprolactinemia and has low biological activity 4, 5

Measure TSH and free T4 immediately to exclude primary hypothyroidism, which commonly causes both hyperprolactinemia and menstrual irregularity 1, 2, 6
Hyperprolactinemia occurs in 43% of women with frank primary hypothyroidism and 36% with subclinical hypothyroidism 4
Treating hypothyroidism alone may normalize prolactin and restore regular menses 1, 2

Order pituitary MRI if prolactin remains persistently elevated on repeat testing to exclude prolactinoma or other pituitary pathology 1, 2
Prolactin levels >4,000 mU/L typically indicate prolactinoma, though microprolactinomas can present with lower levels 3, 5, 1

Measure total testosterone, free testosterone, androstenedione, and DHEA-S to characterize the androgen profile 1, 6
DHEA-S is primarily of adrenal origin; markedly elevated levels suggest adrenal pathology including non-classical congenital adrenal hyperplasia or adrenal tumor 6

Measure mid-luteal progesterone with levels <6 nmol/L indicating anovulation 1, 2, 6
Measure LH and FSH between days 3-6 of the menstrual cycle, with three estimations taken 20 minutes apart for accuracy 2, 6
An LH/FSH ratio >2 is suggestive of PCOS 2, 6

Hyperprolactinemia itself causes anovulation by inhibiting gonadotrophin secretion via suppression of kisspeptin, making it difficult to initially distinguish from PCOS 3, 5, 1
The combination of hyperprolactinemia and elevated DHEA-S is unusual and requires investigation of both the pituitary and adrenal axes separately 7

Treat primary hypothyroidism appropriately, as this alone may normalize prolactin and restore regular menses 1, 2
Address metabolic factors including weight management and insulin resistance in PCOS patients 1, 2
Consider metformin if insulin resistance is present in PCOS patients 1, 2
Use hormonal contraceptives for cycle regulation if pregnancy is not desired in PCOS patients 1, 2
Non-classical congenital adrenal hyperplasia requires glucocorticoid therapy 6
Adrenal tumors require surgical evaluation 6

Consider genetic testing for familial isolated pituitary adenoma or MEN1 syndrome, even without known family history, particularly in younger patients with prolactinomas 3, 5, 1

In women undergoing evaluation for infertility, follicle‑stimulating hormone (FSH) levels of approximately 5 IU/L and luteinizing hormone (LH) levels of about 7 IU/L fall within the normal follicular‑phase reference ranges (FSH 5‑20 IU/L; LH 5‑22 IU/L), indicating that hypopituitarism is unlikely. 8

A luteinizing‑to‑follicle‑stimulating hormone (LH/FSH) ratio greater than 2 is a characteristic biochemical feature of PCOS; a ratio of approximately 1.4 (LH 7.2 IU/L ÷ FSH 5.3 IU/L) therefore argues against a PCOS diagnosis in this clinical context. 8